ABSTRACT
This study aimed at evaluating the role of the emerging non-traditional risk factors, their impact on Cardiovascular Disease [CVD] prediction-together with traditional RFs-in Chronic Kidney Disease [CKD] and end-stage renal disease [ESRD] patients. Total homocysteine [tHcy], plasma fibrinogen [Fbg], plasma factor VII activity [FVIIc], anaemia [HCT] and C-reactive protein [CRP], were studied in 37 Egyptian patients classified into chronic kidney disease group [10 cases] and hemodialysis [HD] group [27 cases] in addition to 10 healthy age and sex-matched controls. This study showed that tHcy, fbg CRP and FVIIc demonstrated highly significant increase in the total patient group and in the HD group compared to the normal controls. These values showed a progressive increase with the disease approaching hemodialysis dependence. Among the 37 patients, 21 showed evidence of ischemic heart disease [IHD]. A statistically significant elevation of the previous factors was found in IHD when compared to non-ischemic group of patients. Multivariante analysis showed CRP as the most predictive risk factor for CVE in CKD and ESRD patients. Therefore, it was concluded that the emerging non-traditional factors studied could explain to a great extent-together with traditional RFs- the high rate of CVD in these patients and that CRP is the most fulfilling for being recommended in clinical practice. Alterations of these factors will aid prevention of coronary heart disease [CHD], thus benefiting the patient from risk factor modification